CDKN2A and neoplasm: The tumor-suppressor products of CDKN2A/B, p15INK4b, and p16INK4a inhibit important CDKs, i.e., CDK4 and CDK6, essential for β-cell proliferation and regeneration (Krishnamurthy et al., 2006).